Literature DB >> 11754001

Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells.

Maurizio Chiriva-Internati1, Yong Liu, Emanuela Salati, Weiping Zhou, Zhiqing Wang, Fabio Grizzi, Juan J Roman, Seah H Lim, Paul L Hermonat.   

Abstract

Adeno-associated virus (AAV) is able to efficiently deliver a cytokine gene into dendritic cells (DC). Improvements in T cell priming by DC might be effected by the delivery of antigen genes into DC, resulting in continuous protein expression, as most proteins have short half-lives. In this study, a recombinant AAV vector containing the human papillomavirus (HPV)-16 E7 gene was used to pulse/infect DC and compared to the pulsing of DC by the lipofection of bacterially produced E7 protein. Pulsing of DC with AAV/antigen (Ag) gene was found to be superior to pulsing with protein in six different assay systems: (1) the level of antigen transfer into DC as determined by intracellular staining; (2) the level of MHC class I-restricted killing in cytotoxic T lymphocyte (CTL) assays; (3) the level of IFN-gamma expression; (4) the level of DC-T cell priming clusters generated; (5) the level of CD80 and CD83 expression on DC; and (6) in the resulting CD8:CD4 ratio. Finally, AAV/Ag gene pulsing resulted in strong CTL activity after only 7 days of priming. These data suggest that AAV vectors may offer advantages over the commonly used protein-pulsing technique and that AAV vectors may be useful for the stimulation of CTL activity and adoptive immunotherapy protocols.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11754001     DOI: 10.1002/1521-4141(200201)32:1<30::AID-IMMU30>3.0.CO;2-E

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

Review 1.  Adenoassociated virus vectors for genetic immunization.

Authors:  Selvarangan Ponnazhagan
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

Review 2.  Adeno-associated virus vectors: potential applications for cancer gene therapy.

Authors:  Chengwen Li; Dawn E Bowles; Terry van Dyke; Richard Jude Samulski
Journal:  Cancer Gene Ther       Date:  2005-12       Impact factor: 5.987

Review 3.  Immunological treatment of liver tumors.

Authors:  Maurizio Chiriva-Internati; Fabio Grizzi; Cynthia A Jumper; Everardo Cobos; Paul L Hermonat; Eldo E Frezza
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

4.  Induction of robust immune responses against human immunodeficiency virus is supported by the inherent tropism of adeno-associated virus type 5 for dendritic cells.

Authors:  Ke-Qin Xin; Hiroaki Mizukami; Masashi Urabe; Yoshihiko Toda; Kaori Shinoda; Atsushi Yoshida; Kenji Oomura; Yoshitsugu Kojima; Motohide Ichino; Dennis Klinman; Keiya Ozawa; Kenji Okuda
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

5.  Major subsets of human dendritic cells are efficiently transduced by self-complementary adeno-associated virus vectors 1 and 2.

Authors:  Philippe Veron; Valérie Allo; Christel Rivière; Jacky Bernard; Anne-Marie Douar; Carole Masurier
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

Review 6.  Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma.

Authors:  Christopher Schutt; Klaus Bumm; Leonardo Mirandola; Giovanni Bernardini; Nicholas D' Cunha; Lukman Tijani; Diane Nguyen; Joehassin Cordero; Marjorie R Jenkins; Everardo Cobos; W Martin Kast; Maurizio Chiriva-Internati
Journal:  Int Rev Immunol       Date:  2012-02       Impact factor: 5.311

7.  Increased expression of programmed death (PD)-1 and its ligand PD-L1 correlates with impaired cell-mediated immunity in high-risk human papillomavirus-related cervical intraepithelial neoplasia.

Authors:  Wen Yang; Yan Song; Yun-Long Lu; Jun-Zhong Sun; Hong-Wei Wang
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

8.  CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model.

Authors:  Tai-Gyu Kim; Chang-Hyun Kim; Eun Ha Won; Su Mi Bae; Woong-Shick Ahn; Jae-Bok Park; Jeong-Im Sin
Journal:  Immunology       Date:  2004-05       Impact factor: 7.397

9.  Highly efficient transduction of human plasmacytoid dendritic cells without phenotypic and functional maturation.

Authors:  Philippe Veron; Sylvie Boutin; Samia Martin; Laurence Chaperot; Joel Plumas; Jean Davoust; Carole Masurier
Journal:  J Transl Med       Date:  2009-01-27       Impact factor: 5.531

10.  Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunity.

Authors:  Jing-Yue Yang; Xiao Li; Li Gao; Zeng-Hui Teng; Wen-Chao Liu
Journal:  Exp Ther Med       Date:  2012-07-06       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.